Steatosis as risk factor for drug-induced liver injury (DILI)

被引：0
|
作者：
Kostadinova, R. [1 ]
Filippi, B. [1 ]
Moritz, W. [1 ]
Pajak, A. [1 ]
Sanchez, K. [1 ]
Wolf, A. [1 ]
机构：
[1] InSphero AG, Schlieren, Switzerland
来源：
TOXICOLOGY LETTERS | 2021年 / 350卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P15-08
引用
下载
收藏
页码：S163 / S164
页数：2
相关论文
共 50 条
  • [21] Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic
    Moreno, Luis
    Sanchez-Delgado, Jordi
    Vergara, Mercedes
    Casas, Meritxell
    Miquel, Mireia
    Dalmau, Blai
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (12) : 767 - 768
  • [22] Drug-Induced Liver Injury (DILI) Does Not Always Follow the Textbook
    Ajayi, Teminioluwa A.
    Dawodu, Ejemenare A.
    Huh, Won J.
    Scanga, Andrew E.
    Izzy, Manhal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1312 - S1313
  • [23] Biomarkers of idiosyncratic drug-induced liver injury (DILI)-a systematic review
    Atallah, Edmond
    Freixo, Cristiana
    Alvarez-Alvarez, Ismael
    Cubero, F. J.
    Gerbes, Alexander L.
    Kullak-Ublick, Gerd A.
    Aithal, Guruprasad P.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (11) : 1327 - 1343
  • [24] Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
    Quintas, Guillermo
    Martinez-Sena, Teresa
    Conde, Isabel
    Pareja Ibars, Eugenia
    Kleinjans, Jos
    Castell, Jose, V
    ARCHIVES OF TOXICOLOGY, 2021, 95 (09) : 3049 - 3062
  • [25] DRUG-INDUCED LIVER INJURY (DILI) AN INTERNATIONAL CONCEPT WITH NATIONAL VARIATIONS
    Lucena, M. I.
    Medina-Caliz, I.
    Gonzalez-Jimenez, A.
    Bessone, F.
    Hernandez, N.
    Sanchez, A.
    di Pace, M.
    Arrese, M.
    Brahm, J. R.
    Ruiz, A.
    Arancibia, J.
    Girala, M.
    Kershenobich, D.
    Loaeza, A.
    Lizarzabal, M.
    Mengual, E.
    Davalos, M.
    Stephens, C.
    Robles-Doaz, M.
    Andrade, R. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 28 - 29
  • [26] A Rare Case of Drug-Induced Liver Injury (DILI) Due to Valproate Hepatocellular Injury
    Baldwin, Hope
    Jafri, Syed-Mohammed
    Elbanna, Ahmed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2087 - S2088
  • [27] Drug-Induced Liver Injury (DILI) related to Propylthiouracil (PTU) in hyperthyroidism with liver cirrhosis
    Salsabila, Arina
    Kholili, Ulfa
    Novida, Hermina
    BALI MEDICAL JOURNAL, 2023, 12 (02) : 1594 - 1600
  • [28] Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China
    Li, Xu
    Wang, Le
    Li, Dezhao
    Niu, Junqi
    Gao, Pujun
    MEDICAL SCIENCE MONITOR, 2019, 25 : 3344 - 3353
  • [29] Infliximab (IFX)-Biosimilar Induced Drug-Induced Liver Injury (DILI): A Case Report
    Zachou, Maria
    Pikramenos, Konstantinos
    Panoutsakou, Maria
    Lalla, Efthimia
    Androutsakos, Theodoros
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [30] Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
    Danjuma, Mohammed
    Elgara, Mohamed
    Al-Hattab, Fatima
    Abaro, Rumaisa
    Elzouki, Abdel-Naser
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (07) : 934 - 935
12345